NucleusRX LLC
Martinsville, NJ, US· latest recorded location
NucleusRX LLC is named on 2 US grants and 2 published applications in this corpus. Its most frequent classification is A61J (Containers specially adapted for medical or pharmaceutical purposes).
- Granted patents
- 2
- Published applications
- 2
- Inventors
- 6
- Granted in 2026 so far
- 1
- Most recent grant
- 11 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2020 | 0 | 1 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 1 | 1 |
| 2024 | 0 | 0 |
| 2025 | 0 | 0 |
| 2026 | 1 | 0 |
By publication year. 2026 runs to 8 Oct.
Technology areas
Share of 4 documents
- A61JContainers specially adapted for medical or pharmaceutical purposes4
- G16HHealthcare informatics, i.e. information and communication technology [ict] specially adapted for the4
- A61BMedical diagnosis and surgery2
- B65GTransport or storage devices2
- G05BControl or regulating systems in general2
- G06QInformation and communication technology [ict] specially adapted for administrative, commercial, financial, managerial2
- G07FCoin-freed or like apparatus2
Recent patents
Most cited
By later US patents